Skip to content
Back to Guavy Wire
Stocks

KBC Group NV Sells Stake in Merck Amid Cancer Therapy Success

Instruments
MRK
Share

KBC Group NV has reduced its holdings in Merck & Co., Inc. (NYSE:MRK) by selling 86,325 shares in the second quarter, according to the company's most recent SEC filing.

The firm now owns 1,131,286 shares of the company's stock after the sale, representing a 7.1% decrease in its holdings.

As of its latest SEC filing, KBC Group NV's holdings in Merck & Co., Inc. were worth approximately $145,370,000.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc